|
|
Volumn 2, Issue 3, 2002, Pages 247-269
|
|
Impact of recombinant DNA technology and protein engineering on structure-based drug design: case studies of HIV-1 and HCMV proteases.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ASSEMBLIN;
PROTEINASE;
PROTEINASE INHIBITOR;
RECOMBINANT DNA;
SERINE PROTEINASE;
BIOTECHNOLOGY;
CHEMISTRY;
DRUG DESIGN;
HUMAN;
METHODOLOGY;
PROTEIN ENGINEERING;
REVIEW;
BIOTECHNOLOGY;
DNA, RECOMBINANT;
DRUG DESIGN;
HIV PROTEASE;
HUMANS;
PROTEASE INHIBITORS;
PROTEIN ENGINEERING;
SERINE ENDOPEPTIDASES;
|
|
EID: 0036511197
PISSN: 15680266
EISSN: None
Source Type: Journal
DOI: 10.2174/1568026023394218 Document Type: Review |
|
Times cited : (8)
|
|
References (125)
|
